BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8702532)

  • 1. Suppression of syndecan-1 expression in endothelial cells by tumor necrosis factor-alpha.
    Kainulainen V; Nelimarkka L; Järveläinen H; Laato M; Jalkanen M; Elenius K
    J Biol Chem; 1996 Aug; 271(31):18759-66. PubMed ID: 8702532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced expression of syndecan in healing wounds.
    Elenius K; Vainio S; Laato M; Salmivirta M; Thesleff I; Jalkanen M
    J Cell Biol; 1991 Aug; 114(3):585-95. PubMed ID: 1860887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of epithelial syndecan-1 expression by inflammatory cytokines.
    Day RM; Mitchell TJ; Knight SC; Forbes A
    Cytokine; 2003 Mar; 21(5):224-33. PubMed ID: 12824007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation.
    Subramanian SV; Fitzgerald ML; Bernfield M
    J Biol Chem; 1997 Jun; 272(23):14713-20. PubMed ID: 9169435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of syndecans, a heparan sulfate proteoglycan, in malignant gliomas: participation of nuclear factor-kappaB in upregulation of syndecan-1 expression.
    Watanabe A; Mabuchi T; Satoh E; Furuya K; Zhang L; Maeda S; Naganuma H
    J Neurooncol; 2006 Mar; 77(1):25-32. PubMed ID: 16132527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular matrix-dependent activation of syndecan-1 expression in keratinocyte growth factor-treated keratinocytes.
    Määttä A; Jaakkola P; Jalkanen M
    J Biol Chem; 1999 Apr; 274(14):9891-8. PubMed ID: 10092681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse.
    Stepp MA; Gibson HE; Gala PH; Iglesia DD; Pajoohesh-Ganji A; Pal-Ghosh S; Brown M; Aquino C; Schwartz AM; Goldberger O; Hinkes MT; Bernfield M
    J Cell Sci; 2002 Dec; 115(Pt 23):4517-31. PubMed ID: 12414997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of syndecan-1 in female reproductive tract tissues and cultured keratinocytes.
    Inki P
    Mol Hum Reprod; 1997 Apr; 3(4):299-305. PubMed ID: 9237257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression and distribution of syndecan-1 and -2 in periodontal wound healing of the rat.
    Worapamorn W; Xiao Y; Li H; Young WG; Bartold PM
    J Periodontal Res; 2002 Aug; 37(4):293-9. PubMed ID: 12200974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of syndecan expression by osteosarcoma cell lines in response to cytokines but not osteotropic hormones.
    Birch MA; Skerry TM
    Bone; 1999 Jun; 24(6):571-8. PubMed ID: 10375199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wound reepithelialization activates a growth factor-responsive enhancer in migrating keratinocytes.
    Jaakkola P; Kontusaari S; Kauppi T; Määtä A; Jalkanen M
    FASEB J; 1998 Aug; 12(11):959-69. PubMed ID: 9707168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of syndecan-1 in human gastric mucosa associated with ulceration.
    Tanabe H; Yokota K; Kohgo Y
    J Pathol; 1999 Feb; 187(3):338-44. PubMed ID: 10398089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of syndecan-1 in leukocyte-endothelial interactions in the ocular vasculature.
    Götte M; Joussen AM; Klein C; Andre P; Wagner DD; Hinkes MT; Kirchhof B; Adamis AP; Bernfield M
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1135-41. PubMed ID: 11923257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of syndecan-1 is induced by differentiation and suppressed by malignant transformation of human keratinocytes.
    Inki P; Larjava H; Haapasalmi K; Miettinen HM; Grenman R; Jalkanen M
    Eur J Cell Biol; 1994 Feb; 63(1):43-51. PubMed ID: 8005104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds.
    Gallo RL; Ono M; Povsic T; Page C; Eriksson E; Klagsbrun M; Bernfield M
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11035-9. PubMed ID: 7972004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent.
    Leppä S; Vleminckx K; Van Roy F; Jalkanen M
    J Cell Sci; 1996 Jun; 109 ( Pt 6)():1393-403. PubMed ID: 8799827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proximal promoter of the murine syndecan-1 gene is not sufficient for the developmental pattern of syndecan expression in B lineage cells.
    Volpe CP; Lundgren A; Aints A; Mohamed AJ; Jaakkola P; Christensson B; Gahrton G; Jalkanen M; Smith CI; Dilber MS
    Am J Hematol; 2001 May; 67(1):20-6. PubMed ID: 11279653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by the soluble syndecan-1 ectodomains delays wound repair in mice overexpressing syndecan-1.
    Elenius V; Götte M; Reizes O; Elenius K; Bernfield M
    J Biol Chem; 2004 Oct; 279(40):41928-35. PubMed ID: 15220342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine regulation of syndecan expression in cells of liver origin.
    Sebestyén A; Gallai M; Knittel T; Ambrust T; Ramadori G; Kovalszky I
    Cytokine; 2000 Oct; 12(10):1557-60. PubMed ID: 11023673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of syndecan-1 mRNA in cervical-carcinoma cells is involved with the 3' untranslated region.
    Nakanishi K; Yoshioka N; Oka K; Hakura A
    Int J Cancer; 1999 Feb; 80(4):527-32. PubMed ID: 9935152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.